Translational Session
Kidney Health Initiative: Developing Tools to Catalyze Innovation
October 23, 2020 | 02:30 PM - 04:30 PM
Location: Simulive
Session Description
The Kidney Health Initiative (KHI) supports the kidney community in its efforts to develop safe and effective patient-centered products by addressing real and substantial barriers. This session uses four current KHI projects as case studies. Each presenter explains why there was a barrier to innovation; how they have navigated the complex world of product development, including how to engage diverse stakeholders; and how the final deliverable in their case contributes to an ecosystem of rich tools and assets that the community can build on.
ASN thanks the Kidney Health Initiative for assistance with this session.
Learning Objective(s)
- Discuss how public-private partnership can catalyze innovation through collaboration
- Specify tools available to support research and patient-centered therapies for ESRD
- Identify opportunities to collaborate for better AKI trials
Learning Pathway(s)
- Other
Moderators
- Barbara S. Gillespie, MD, FASN
- Raymond C. Harris, MD, FASN
Presentations
- Multi-Stakeholder Engagement to Identify Clinical Trial Endpoints for Drug Development in Rare Disease
02:30 PM - 03:00 PM
W. Todd Lowther, PhD
- Prioritizing Muscle Cramping as a Patient-Reported Outcome
03:00 PM - 03:30 PM
Michelle M. Richardson, PharmD
- Catalyzing the Development of Biomarkers for AKI Through Stakeholder Engagement
03:30 PM - 04:00 PM
Aliza M. Thompson, MD, MS
- Supporting the Development of an Artificial Kidney Through Patient and Innovator Feedback
04:00 PM - 04:30 PM
Frank P. Hurst, MD, FASN
